-+ 0.00%
-+ 0.00%
-+ 0.00%

HLS Therapeutics schedules Q3 2026 financial results conference call

PUBT·10/29/2026 11:06:28
HLS Therapeutics schedules Q3 2026 financial results conference call
  • HLS Therapeutics to release third-quarter and nine-month financial results for periods ended Sept. 30, 2026, on Nov. 12, 2026.
  • A conference call to discuss the results is scheduled for Nov. 12, 2026, at 9:30 a.m. ET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HLS Therapeutics Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202610290700CANADANWCANADAPR_C0402) on October 29, 2026, and is solely responsible for the information contained therein.